30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

KB Medical Closes Series B Financing -

KB Medical raised CHF 2.5MM (~US $2.51MM) in a Series B Financing. Funds will support FDA approval and upgrade validations for the AQrate™ Robotic Assistance System V 1.2. for spinal surgery.

The company's first product has completed clinical trials in spinal fusion on 24 patients and received CE Mark approval in 2Q16. Restricted launch will begin in 2017. 

Additional functionality to be added to AQrate includes proprietary anti-skiving technology. 

Sources: KB Medical SA; ORTHOWORLD Inc.


This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.